FDA Investigator Pei I Chu
Pei I Chu has inspections in 1 countries as of 19 Jun 2023. Pei I Chu has collaborated with a combined 480 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
19 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India
Co-Investigator(s):
Angela E Glenn,
Charisse K Green,
Cheryl A Clausen,
Devaughn Edwards,
Jonah S Ufferfilge,
Jose Alopez Rubet,
June P Page,
Justin A Boyd,
Kenneth H Williams,
Kevin A Gonzalez,
Megan A Haggerty,
Michael A Charles,
Michele Perry Williams,
Nicholas A Violand,
Nicole E Knowlton,
Parul M Patel,
Rajiv R Srivastava,
Ralph H Vocque,
Ramon E Martinez,
Rebecca E Dombrowski,
Scott B Laufenberg,
Sharon K Thoma, PharmD,
Sixto M Mercado Rios,
Stephen D Brown,
Teresa I Navas,
Thomas J Arista
Pei I Chu's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2018 | FDA 483 | CIPLA LIMITED - Form 483, 2018-09-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more